327036-89-5
Chemical Structure
TDZD-8
Synonym(s): GSK-3β Inhibitor I; NP 01139
- CAS No.: 327036-89-5
- Formula:C10H10N2O2S
- Molecular Weight:222.26
IUPAC Name: 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
InChIKey: JDSJDASOXWCHPN-UHFFFAOYSA-N
SMILES: O=C(N1CC2=CC=CC=C2)N(C)SC1=O
Biological Activity: TDZD-8 is an inhibitor of GSK-3β, with an IC50 of 2 μM; TDZD-8 shows less potent activities against Cdk-1/cyclin B, CK-II, PKA, and PKC, with all IC50s of >100 μM.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TDZD-8 | 99.76% | TDZD-8 is an inhibitor of GSK-3β, with an IC50 of 2 μM; TDZD-8 shows less potent activities against Cdk-1/cyclin B, CK-II, PKA, and PKC, with all IC50s of >100 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
TDZD-8 (Standard) | ≥98% | TDZD-8 (Standard) is the analytical standard of TDZD-8. This product is intended for research and analytical applications. TDZD-8 is an inhibitor of GSK-3β, with an IC50 of 2 μM; TDZD-8 shows less potent activities against Cdk-1/cyclin B, CK-II, PKA, and PKC, with all IC50s of >100 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords